Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation process of medicine for treating chronic pulmonary heart disease

A technology for pulmonary heart disease and preparation process, which is applied in the directions of drug combination, cardiovascular system diseases, medical preparations containing active ingredients, etc., to achieve the effects of simple component ratio, good therapeutic effect and low price

Inactive Publication Date: 2019-03-01
GUANGDONG HONGRUI TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the therapeutic effect of chronic cor pulmonale is extremely limited, in order to overcome this type of treatment problem, it is the purpose of the present invention's research

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0010] Embodiment 1: A kind of medicine preparation process for the treatment of chronic cor pulmonale, comprising midecamycin, co-trimoxazole, cephalexin, ciprofloxacin, ampicillin, cefazolin, cefoperazone and cefzizime described midecamycin 0.5g; described cotrimoxazole 0.2g; described cephalexin 0.5g; described ciprofloxacin 0.3g; described ampicillin 4g; 0.5 g of morphine; each 2 g of the cefoperazone; 2 g of the cefazine; 93.6 g of the saline injection is mixed intravenously, once a day.

Embodiment 2

[0011] Embodiment 2: A kind of medicine preparation process for the treatment of chronic cor pulmonale, comprising midecamycin, co-trimoxazole, cephalexin, ciprofloxacin, ampicillin, cefazolin, cefoperazone and cefzizime described midecamycin 0.5g; described cotrimoxazole 0.2g; described cephalexin 0.5g; described ciprofloxacin 0.3g; described ampicillin 4g; 0.5 g of morphine; 97.6 g of the physiological saline injection was mixed for intravenous infusion; at the same time, cefoperazone and cefotaxime were selected and added to 300-500 ml of 0.9% sodium chloride injection respectively, and intravenous infusion was performed separately. Note; once a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation process of a medicine for treating chronic pulmonary heart disease. The medicine is prepared from 0.5-1 g of midecamycin, 0.03-0.2 g of compound sulfamethoxazole, 0.5 g of cefalexin, 0.3-0.5 g of ciprofloxacin, 4-6 g of ampicillin, 0.5-1 g of cefazolin, 2-4 g of cefoperazone each time and 2-4 g of cefodizime. 100 parts of the medicine are matched with a normal saline injection for intravenous drip once every day. The medicine has the benefits as follows: the treatment effect is good, the component ratio is simple, and the cost is low.

Description

technical field [0001] The invention relates to a preparation process of a heart disease drug, in particular to a preparation process of a drug for treating chronic pulmonary heart disease, and belongs to the field of drug preparation. Background technique [0002] Chronic cor pulmonale, also known as cor pulmonale, is caused by chronic lesions in the lung tissue, pulmonary arteries, or thorax, resulting in abnormal lung tissue structure and function, resulting in increased pulmonary vascular resistance and increased pulmonary artery pressure, resulting in right heart dilatation and hypertrophy, accompanied by or Heart disease without right heart failure. The vast majority of cor pulmonale patients in my country develop on the basis of chronic bronchitis or emphysema. [0003] At present, the treatment effect of chronic cor pulmonale is extremely limited, in order to overcome this kind of treatment problem, it is the purpose of the research of the present invention. Conte...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/635A61K31/505A61K31/545A61K31/496A61K31/431A61K31/43A61K31/546A61K31/7048A61P11/00A61P9/00
CPCA61K31/635A61K31/43A61K31/431A61K31/496A61K31/505A61K31/545A61K31/546A61K31/7048A61K2300/00
Inventor 梁沛明
Owner GUANGDONG HONGRUI TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com